Chronic kidney disease

AstraZeneca’s IMPACT CKD Model Forecasts Alarming Rise in Chronic Kidney Disease by 2032

(IN BRIEF) AstraZeneca's IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up…

2 weeks ago

Novartis Reports Positive Results for Atrasentan in IgA Nephropathy Study

(IN BRIEF) Novartis has reported positive interim results from its Phase III ALIGN study involving atrasentan, an oral endothelin A…

6 months ago

GlaxoSmithKline: European Medicines Agency (EMA) validated the marketing authorisation application (MAA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor used to treat patients with anaemia of chronic kidney disease

Submission for the treatment of anaemia of chronic kidney disease based on the ASCEND Phase III clinical trial programme, consisting…

2 years ago

New data from AstraZeneca’s renal medicines will be presented at the 57th European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress

(PRESS RELEASE) CAMBRIDGE, 5-Jun-2020 — /EuropaWire/ — British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca announced it will present new data…

4 years ago

Hyperkalaemia: Japan’s Ministry of Health, Labour and Welfare has approved AstraZeneca’s Lokelma

(PRESS RELEASE) CAMBRIDGE, 26-Mar-2020 — /EuropaWire/ — Science-led biopharmaceutical group AstraZeneca (LSE/STO/NYSE: AZN) has announced that its Lokelma (sodium zirconium…

4 years ago

AstraZeneca will use BenevolentAI’s advanced AI to dive into its disease area expertise and massive datasets to gain insights into the complex disease biology

AstraZeneca / BenevolentAI artificial intelligence collaboration will accelerate drug discovery Potential new drugs discovery in the area of chronic kidney…

5 years ago

University of Birmingham study links periodontitis to higher mortality rate in patients with chronic kidney disease

BIRMINGHAM, 19-Feb-2016 — /EuropaWire/ — New findings from the University of Birmingham show that patients with chronic kidney disease patients and…

8 years ago

National Institute for Health Research (NIHR) Clinician Scientist Award for new University of Leicester research into preventing heart disease in dialysis patients

National award for new University of Leicester research into preventing heart disease in dialysis patients Leicester, UK, 10-2-2014 — /EuropaWire/ —…

10 years ago